Related Experiment Video
Updated: Aug 13, 2026

14:29
Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
Published on: October 1, 2012
Total synthesis of (+)-blasticidin s
Yoshiyasu Ichikawa1, Keiko Hirata, Masayoshi Ohbayashi
1Laboratory of Organic Chemistry, School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya 464-8601, Japan. ichikawa@agr.nagoya-u.ac.jp
Chemistry (Weinheim an Der Bergstrasse, Germany)
|June 30, 2004
Summary
Researchers achieved the first total synthesis of blasticidin S, a peptidyl nucleoside antibiotic. This breakthrough involved coupling cytosinine and blastidic acid, paving the way for future antibiotic research.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Synthetic Biology
Background:
- Blasticidin S is a peptidyl nucleoside antibiotic with significant biological activity.
- Previous efforts have not achieved a total synthesis of this complex molecule.
- Understanding its synthesis is crucial for developing novel analogs and therapeutics.
Purpose of the Study:
- To achieve the first total synthesis of blasticidin S.
- To develop efficient and stereoselective synthetic routes for key intermediates.
- To establish a reliable method for assembling the blasticidin S structure.
Main Methods:
- The synthesis involved the coupling of cytosinine and blastidic acid.
- Key steps included a sigmatropic rearrangement for cytosinine synthesis and Weinreb/Fukuyama protocols for blastidic acid.
- The Vorbrüggen conditions and BOP method were employed for N-glycosylation and fragment coupling, respectively.
Main Results:
- The total synthesis of blasticidin S was successfully accomplished.
- Efficient and stereoselective access to crucial intermediates like cytosinine and blastidic acid was achieved.
- The synthesis yielded blasticidin S through a multi-step process with a 4.0% overall yield for cytosinine and 23% for blastidic acid.
Conclusions:
- The first total synthesis of blasticidin S has been successfully established.
- The developed synthetic strategy provides a robust platform for future modifications and analog development.
- This work opens new avenues for the exploration of blasticidin S derivatives as potential therapeutic agents.

